Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003)

ClinicalTrials.gov ID: NCT00105534

Public ClinicalTrials.gov record NCT00105534. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 1:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study to Evaluate the Clinical and Microbial Efficacy and Safety of 1.0 % AzaSite Compared to Vehicle in the Treatment of Bacterial Conjunctivitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the clinical and microbial efficacy and safety of AzaSite compared to vehicle for bacterial conjunctivitis. Adults and children one year of age and older with bacterial conjunctivitis in at least one eye may be eligible. Subjects will be randomly assigned to receive either 1.0 % AzaSite or Vehicle. Three visits will be required for this study.

Study identification

NCT ID
NCT00105534
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
685 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
12 Months and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2004
Primary completion
Dec 31, 2005
Completion
Dec 31, 2005
Last update posted
Nov 20, 2013

2004 – 2006

United States locations

U.S. sites
32
U.S. states
18
U.S. cities
30
Facility City State ZIP Site status
I Care! Eye Care! Flagstaff Arizona 86001
Rx For Life, Inc. Cudahy California 90201
North Bay Eye Associates Petaluma and Santa Rosa California 95401
San Diego Eye and Laser Center San Diego California 92123
Western States Clinical Research Wheat Ridge Colorado 80033
Opticare Eye Health Center Waterbury Connecticut 06708
International Eye Center Tampa Florida 33603
Welborn Clinic and Welborn Clinic East Evansville Indiana 47713
Taustine Eye Center Louisville Kentucky 40217
Bossier Optical Inc. Bossier City Louisiana 71111
Bohn and Joseph Eye Center Lafayette Louisiana 70506
The Louisiana Eye Center Zachary Louisiana 70791
Mississippi Eye Associates Ocean Springs Mississippi 39564
Clinical Research Laboratories Piscataway New Jersey 08854
Advanced Eyecare and Laser Center Runnemede New Jersey 08078
Precision Eye Care Huntington New York 11743
Charlotte Eye, Ear, Nose, and Throat Charlotte North Carolina 28210
Horizon Eye Center Charlotte North Carolina 28211
Groat Eyecare Associates Greensboro North Carolina 27401
Abrams Eye Center Cleveland Ohio 44115
Bend Memorial Clinic Bend Oregon 97701
University Eye Surgeons Maryville Tennessee 37803
Total Eye Care, PA Memphis Tennessee 38119
Eye Associates Nashville Tennessee 37203
Metaclin Research, Inc. Austin Texas 78704
Physicians Eye Associates & Cosmetic Laser Houston Texas 77002
Marc Sanders, MD Houston Texas 77030
Mark Mayo, MD Pasadena Texas 77504
Sun Research Institute San Antonio Texas 78205
Mountain View Eye Center Layton Utah 84041
Cottonwood Eye and Laser Clinic Salt Lake City Utah 84107
Advanced Healthcare, SC Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00105534, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 20, 2013 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00105534 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →